Hematology and Oncology
Build practical clinical judgment in hematology and oncology through clear visual lessons created for international nursing learners and teaching discussions.
55 presentation slides and a matching infographic.
Lesson text and sources
Read alongside the visual presentation. Expand a lesson to review its text, teaching explanation and references.
1. Hematology & Oncology
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 01 / 55 RN Clarity C10 • SYSTEM Hematology & Oncology Follow the pattern beyond the blood count. Independent NCLEX-RN® preparation • USA + Canada
Teaching explanation
This focused course covers blood-cell function, bleeding and clotting disorders, sickle cell complications and oncologic emergencies. It uses fictional cases and practical communication. It does not reproduce chemotherapy regimens or replace specialist competency training. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
2. A laboratory result belongs to a patient
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 02 / 55 RN Clarity A laboratory result belongs to a patient Assess symptoms and clinical stability. Compare relevant results with the trend. Connect the findings with treatment and recent changes.
Teaching explanation
An isolated abnormal value is not a complete assessment. Ask learners what the patient is doing and feeling, what changed and what treatment is underway. The responsible team interprets the cause and treatment need. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
3. Connect blood function with clinical effects
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 03 / 55 RN Clarity Connect blood function with clinical effects 01 Red cells carry oxygen through hemoglobin. 02 Reduced oxygen-carrying capacity can produce symptoms. 03 Assessment links symptoms, cause and the treatment plan. Sources: ANEMIA · Details and public links in notes
Teaching explanation
This flow explains anemia without implying that every fatigue symptom has a hematologic cause. Treatment depends on the cause and clinical context. Do not apply one transfusion threshold to every patient. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
4. Translate the blood-count language
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 04 / 55 RN Clarity Translate the blood-count language 01 Anemia = too few healthy red cells or too little hemoglobin. 02 Neutropenia = a low neutrophil count. 03 Thrombocytopenia = a low platelet count.
Teaching explanation
The terms describe different problems. Neutrophils are a type of white blood cell; neutropenia is not simply any abnormal white-cell count. A low platelet count does not exclude thrombosis. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
5. Build a useful hematology assessment
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 05 / 55 RN Clarity Build a useful hematology assessment 01 Ask about fatigue, breathlessness, bleeding and new pain. 02 Review medicines, cancer treatment and transfusion history. 03 Assess current stability and changes from baseline. Sources: ANEMIA • TX • TEAM · Details and public links in notes
Teaching explanation
Use the actual medicine and treatment names when possible. “On chemo” is incomplete if a new symptom could relate to a specific treatment. Identify the timing and relevant monitoring plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
6. Turn a concerning trend into an action
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 06 / 55 RN Clarity Turn a concerning trend into an action 01 Recognize the change and its possible clinical importance. 02 Escalate with the timeline and relevant treatment history. 03 Reassess while the evaluation and treatment proceed. Sources: TEAM · Details and public links in notes
Teaching explanation
The nurse need not know the final diagnosis before requesting review. The report should state observations, concern and the needed response. Close the loop rather than assuming that a message was seen. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
7. Support anemia care without a shortcut
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 07 / 55 RN Clarity Support anemia care without a shortcut 01 Investigate the cause rather than assume iron deficiency. 02 Follow the prescribed replacement or treatment plan. 03 Reassess symptoms, tolerance and relevant results. Sources: ANEMIA · Details and public links in notes
Teaching explanation
Anemia can reflect different mechanisms. Iron is not the treatment for every anemia, and a blood transfusion is not selected from a single universal number. Explain the individual plan and follow-up in plain language. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
8. Ask about the treatment experience respectfully
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 08 / 55 RN Clarity Ask about the treatment experience respectfully 01 Listen to the patient’s usual symptoms and prior reactions. 02 Avoid labels that dismiss pain or repeated visits. 03 Explain the assessment and invite questions. Sources: ASH • TEAM · Details and public links in notes
Teaching explanation
A familiar patient can still develop a new emergency. Prior experience may provide valuable baseline information. Do not equate repeated pain episodes with an absence of legitimate treatment needs. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Sickle cell disease guidelines
- Locator: Pain, transfusion support and complications
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/sickle-cell-disease-guidelines
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
9. Clotting and bleeding can coexist
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 09 / 55 RN Clarity Clotting and bleeding can coexist 01 DIC can involve widespread coagulation activation. 02 Consumption of clotting components can contribute to bleeding. 03 Treatment addresses the underlying illness and complications. Sources: DIC · Details and public links in notes
Teaching explanation
This is a mechanism overview, not a diagnostic score. DIC may accompany serious illness such as infection or malignancy. The specialist team interprets the clinical picture and tests, and chooses supportive treatment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Disseminated intravascular coagulation
- Locator: 2022; clotting, bleeding and underlying-cause treatment
- https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
10. Escalate the mixed clotting–bleeding pattern
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 10 / 55 RN Clarity Escalate the mixed clotting–bleeding pattern 01 Assess stability, bleeding and signs of organ dysfunction. 02 Report relevant laboratory trends and underlying illness. 03 Prepare for ordered treatment and continued surveillance. Sources: DIC • TEAM · Details and public links in notes
Teaching explanation
Do not assume the problem is confined to visible bleeding. Describe new neurologic, respiratory or perfusion changes. Avoid selecting blood components or anticoagulation independently from a general teaching slide. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Disseminated intravascular coagulation
- Locator: 2022; clotting, bleeding and underlying-cause treatment
- https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
11. DIC, TTP and HIT are different problems
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 11 / 55 RN Clarity DIC, TTP and HIT are different problems 01 DIC: systemic coagulation activation in a clinical context. 02 TTP: small-vessel clots with a distinct disease mechanism. 03 HIT: an immune heparin reaction with thrombotic risk.
Teaching explanation
These conditions are not interchangeable diagnoses for low platelets. TTP requires urgent specialist treatment; acquired and inherited forms have different treatment details. The deck deliberately avoids a one-treatment-fits-all algorithm. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Disseminated intravascular coagulation
- Locator: 2022; clotting, bleeding and underlying-cause treatment
- https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
- NHLBI • Thrombotic thrombocytopenic purpura
- Locator: 2025; small-vessel clotting and specialist treatment
- https://www.nhlbi.nih.gov/health/thrombotic-thrombocytopenic-purpura
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
12. Case 1: low platelets with a new limb concern
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 12 / 55 RN Clarity Case 1: low platelets with a new limb concern FICTIONAL BEDSIDE SCENARIO 01 A patient exposed to heparin develops a falling platelet trend. 02 A leg becomes newly painful and swollen. 03 A learner assumes low platelets mean clotting is unlikely. Sources: HIT · Details and public links in notes
Teaching explanation
Fictional case. Escalate the combined trend and symptoms for urgent evaluation. HIT is one concern, not a diagnosis from these findings alone. Clarify the immediate medication plan through the appropriate protocol and prescriber. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
13. Case 1: report exposure and the new finding
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 13 / 55 RN Clarity Case 1: report exposure and the new finding “The platelet trend is falling after heparin exposure.” “There is new painful leg swelling.” “Please urgently review possible thrombosis and HIT.” Sources: TEAM • HIT · Details and public links in notes
Teaching explanation
Include actual dates, verified counts and the complete heparin exposure history when available. Do not wait for a final confirmatory test before communicating concern. Treatment decisions belong to the responsible clinical team. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
14. Case 1: verify the revised treatment plan
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 14 / 55 RN Clarity Case 1: verify the revised treatment plan 01 Confirm authorized anticoagulation changes. 02 Follow the ordered investigations and monitoring. 03 Communicate new bleeding, thrombosis or deterioration. Sources: HIT • TEAM · Details and public links in notes
Teaching explanation
A low platelet count alone is not a reason to choose a replacement anticoagulant. Ensure the team’s plan is clear and that relevant exposure information follows the patient during transfer. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
15. Sickle cell pain can accompany a new emergency
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 15 / 55 RN Clarity Sickle cell pain can accompany a new emergency 01 Vaso-occlusion can cause severe pain. 02 New respiratory symptoms require additional assessment. 03 Acute chest syndrome is a serious complication. Sources: ASH • SCD · Details and public links in notes
Teaching explanation
Treat pain respectfully and assess for complications in parallel. Do not assume that a previous pain pattern explains every new symptom. The acute chest syndrome diagnosis requires the clinical evaluation, not a pain label alone. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Sickle cell disease guidelines
- Locator: Pain, transfusion support and complications
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/sickle-cell-disease-guidelines
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
16. Respond to a new respiratory change
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 16 / 55 RN Clarity Respond to a new respiratory change 01 Assess breathing, oxygenation and overall stability. 02 Escalate the new chest or respiratory findings. 03 Support the prescribed respiratory and hematology plan. Sources: SCD • TEAM · Details and public links in notes
Teaching explanation
The patient may need hospital-level urgent care. Oxygen, antibiotics and transfusion strategies are selected for the clinical context. Do not prescribe a fixed fluid bolus or assume all sickle cell complications need the same transfusion. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
17. Treat pain and assess new complications
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 17 / 55 RN Clarity Treat pain and assess new complications 01 Reassess pain after prescribed analgesia. 02 Continue monitoring breathing and alertness. 03 Report changes that do not fit the expected response.
Teaching explanation
Relief is important but does not remove the need to assess deterioration. Ask students to distinguish untreated pain from new respiratory compromise or treatment-related sedation without assuming one explanation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Sickle cell disease guidelines
- Locator: Pain, transfusion support and complications
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/sickle-cell-disease-guidelines
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
18. Case 2: new chest symptoms
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 18 / 55 RN Clarity Case 2: new chest symptoms FICTIONAL BEDSIDE SCENARIO 01 A patient admitted with sickle cell pain develops cough. 02 Breathing becomes more difficult and chest discomfort is new. 03 The handoff still describes only the original pain episode. Sources: SCD · Details and public links in notes
Teaching explanation
Fictional case. Urgently communicate the new respiratory pattern and assess stability. Do not wait for the next routine pain review. Acute chest syndrome is a concern that needs clinical evaluation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
19. Case 2: distinguish the new problem
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 19 / 55 RN Clarity Case 2: distinguish the new problem “These respiratory symptoms are new.” “The current picture differs from the admission pain pattern.” “I need urgent assessment for a pulmonary complication.” Sources: TEAM • SCD · Details and public links in notes
Teaching explanation
Use objective observations and the patient’s description. A concise report should preserve the difference from baseline and request a response. Continue the individualized pain plan while the new concern is addressed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
20. Case 2: follow both comfort and breathing
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 20 / 55 RN Clarity Case 2: follow both comfort and breathing 01 Reassess respiratory status and alertness. 02 Confirm the investigation and treatment response. 03 Include the new complication concern in every transition. Sources: SCD • TEAM · Details and public links in notes
Teaching explanation
The receiving team needs more than “pain improved.” Ask what findings would show improvement and what would require renewed escalation. Monitoring frequency follows clinical acuity and local orders. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
21. Transfusion symptoms need prompt attention
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 21 / 55 RN Clarity Transfusion symptoms need prompt attention 01 New fever, rigors, pain or breathing change may be important. 02 A reaction can have several possible causes. 03 Follow the immediate transfusion-reaction pathway. Sources: TX · Details and public links in notes
Teaching explanation
Do not diagnose every fever as a benign reaction. Canadian Blood Services describes multiple reaction types with different treatment needs. Recognize the change, stop a suspected acute reaction exposure according to the reaction pathway, and obtain appropriate help. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
22. Act on a suspected acute transfusion reaction
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 22 / 55 RN Clarity Act on a suspected acute transfusion reaction 01 Stop the transfusion and assess the patient. 02 Notify the clinical team and transfusion service promptly. 03 Follow the local reaction investigation and support protocol. Sources: TX · Details and public links in notes
Teaching explanation
Emergency activation is required for instability. Maintain access and handle the component, tubing and samples according to the local transfusion protocol. Do not independently restart a component because symptoms improve; the responsible team must determine the plan. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
23. A reaction label needs investigation
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 23 / 55 RN Clarity A reaction label needs investigation 01 Breathing difficulty has more than one transfusion-related cause. 02 Clinical findings and timing guide the assessment. 03 Treatment must match the evaluated cause.
Teaching explanation
Avoid treating every respiratory reaction with the same intervention. The deck does not ask a learner to independently distinguish all reaction subtypes at the bedside. It emphasizes prompt response, accurate reporting and specialist review. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
24. Case 3: rigors during a red-cell transfusion
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 24 / 55 RN Clarity Case 3: rigors during a red-cell transfusion FICTIONAL BEDSIDE SCENARIO 01 A patient develops shaking chills during the transfusion. 02 The symptoms were absent at the pretransfusion assessment. 03 A learner suggests simply slowing the infusion. Sources: TX · Details and public links in notes
Teaching explanation
Fictional case. A possible acute reaction needs the reaction pathway, not an unsupported rate adjustment. Stop the transfusion, assess and notify the appropriate teams. Escalate instability immediately. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
25. Case 3: make the timing explicit
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 25 / 55 RN Clarity Case 3: make the timing explicit “The rigors began during this transfusion.” “This is a new change from the starting assessment.” “The transfusion is stopped; urgent reaction review is needed.” Sources: TEAM • TX · Details and public links in notes
Teaching explanation
Report what has actually been done, with the times and relevant observations. Do not state that the event is an allergy or hemolysis before investigation. Preserve identity and component information through the local process. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
26. Case 3: do not close the event at symptom relief
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 26 / 55 RN Clarity Case 3: do not close the event at symptom relief 01 Continue the ordered assessment and monitoring. 02 Complete the required investigation and handoff. 03 Confirm the plan before any further transfusion. Sources: TX • TEAM · Details and public links in notes
Teaching explanation
Symptom improvement does not by itself identify the cause or authorize restarting. The transfusion service and clinical team determine subsequent management. Documentation should clearly distinguish observed facts from suspected causes. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
27. Cancer treatment can increase infection risk
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 27 / 55 RN Clarity Cancer treatment can increase infection risk 01 Neutropenia reduces an important infection defense. 02 Infection can become serious quickly. 03 Fever or other infection concerns need urgent advice. Sources: NEUT · Details and public links in notes
Teaching explanation
The patient’s oncology team should provide exact fever instructions and contact routes. Do not invent one threshold or use absence of a dramatic fever to dismiss deterioration. This slide concerns prompt assessment, not a stand-alone antibiotic order. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
28. Escalate the possible neutropenic infection
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 28 / 55 RN Clarity Escalate the possible neutropenic infection 01 Assess current stability and report recent cancer treatment. 02 Activate the relevant urgent oncology or sepsis pathway. 03 Support timely ordered evaluation and treatment. Sources: NEUT • TEAM · Details and public links in notes
Teaching explanation
The clinical team determines cultures, antimicrobials and disposition. A learner should not delay communication while trying to locate every past result. Reassess while the pathway proceeds. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
29. A fever medicine can hide a useful signal
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 29 / 55 RN Clarity A fever medicine can hide a useful signal 01 Ask about medicines already taken for fever. 02 Do not let a lower temperature erase the history. 03 Follow the oncology team’s instructions for urgent assessment.
Teaching explanation
NCI advises discussing fever medicines with the care team because they can mask signs. This is not a prohibition on clinician-directed antipyretic treatment. Report the prior fever and timing of any medicine. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
30. Case 4: the temperature falls after a home remedy
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 30 / 55 RN Clarity Case 4: the temperature falls after a home remedy FICTIONAL BEDSIDE SCENARIO 01 After cancer treatment, a patient develops fever and chills. 02 A fever-reducing medicine lowers the temperature. 03 He wonders whether that means he can skip contacting oncology. Sources: NEUT · Details and public links in notes
Teaching explanation
Fictional case. Advise following the urgent oncology contact plan and report the original symptoms and medicine taken. Improvement in one reading does not establish that a serious infection is absent. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
31. Case 4: preserve the symptom history
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 31 / 55 RN Clarity Case 4: preserve the symptom history “The fever and chills began after recent treatment.” “A fever medicine was taken before this reading.” “The patient needs the urgent oncology assessment pathway.” Sources: TEAM • NEUT · Details and public links in notes
Teaching explanation
This report prevents the receiving team from seeing only a lower current temperature. Add the actual treatment and timeline when verified. Escalate immediately if the patient is unstable. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
32. Case 4: make follow-through practical
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 32 / 55 RN Clarity Case 4: make follow-through practical 01 Confirm where and how the patient will be assessed. 02 Communicate access barriers or worsening symptoms. 03 Recheck that the urgent plan was understood. Sources: TEAM · Details and public links in notes
Teaching explanation
A phone instruction may fail if transport, language or contact details are unclear. Use teach-back and resolve barriers with the team. Do not treat a sent message as evidence that the patient received care. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
33. Tumor lysis can disrupt electrolytes and kidneys
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 33 / 55 RN Clarity Tumor lysis can disrupt electrolytes and kidneys 01 Rapid cancer-cell breakdown releases intracellular contents. 02 Potassium, phosphate and uric acid can rise; calcium can fall. 03 Severe abnormalities can threaten cardiac and kidney function. Sources: LYSIS · Details and public links in notes
Teaching explanation
This is the characteristic pattern, not a diagnostic threshold table. TLS needs urgent treatment. The nurse follows the risk-based laboratory, fluid and monitoring plan and reports emerging abnormalities promptly. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
34. Connect treatment timing with the new pattern
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 34 / 55 RN Clarity Connect treatment timing with the new pattern 01 Identify TLS risk and the prescribed surveillance plan. 02 Report changes in laboratory results, urine and symptoms. 03 Escalate significant abnormalities or deterioration. Sources: TLS • LYSIS • TEAM · Details and public links in notes
Teaching explanation
TLS can occur spontaneously or with cancer treatment. Do not restrict suspicion to one chemotherapy drug or one exact time window. Fluid and urate-lowering treatment require patient-specific orders and monitoring. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Tumor lysis syndrome
- Locator: May 2024; spontaneous or treatment-associated TLS
- https://emergencycarebc.ca/clinical_resource/clinical-summary/tumor-lysis-syndrome/
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
35. Recognize oncologic emergencies
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 35 / 55 RN Clarity Recognize oncologic emergencies 01 TLS may present with metabolic or kidney changes. 02 New neurologic symptoms can signal cord compression. 03 Treatment-related organ inflammation also needs assessment.
Teaching explanation
The brief comparison is a recognition map. It does not imply that every symptom proves one of these emergencies. The clinical context and evaluation determine the cause and urgent treatment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Tumor lysis syndrome
- Locator: May 2024; spontaneous or treatment-associated TLS
- https://emergencycarebc.ca/clinical_resource/clinical-summary/tumor-lysis-syndrome/
- Canadian Cancer Society • Spinal cord compression
- Locator: Urgent recognition and treatment
- https://cancer.ca/en/treatments/side-effects/spinal-cord-compression
- NCI • Organ-related inflammation
- Locator: Immunotherapy-associated organ symptoms
- https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation
36. Case 5: new weakness and reduced urine output
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 36 / 55 RN Clarity Case 5: new weakness and reduced urine output FICTIONAL BEDSIDE SCENARIO 01 A patient with a high-burden malignancy starts treatment. 02 New weakness appears and urine output declines. 03 The latest chemistry results also show a concerning change. Sources: TLS • LYSIS · Details and public links in notes
Teaching explanation
Fictional case. Escalate the combined clinical and laboratory pattern for possible TLS and other causes. Do not wait for a fully developed syndrome before reporting. The specific abnormal results should be stated when known. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Emergency Care BC • Tumor lysis syndrome
- Locator: May 2024; spontaneous or treatment-associated TLS
- https://emergencycarebc.ca/clinical_resource/clinical-summary/tumor-lysis-syndrome/
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
37. Case 5: connect the findings in one report
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 37 / 55 RN Clarity Case 5: connect the findings in one report “These changes followed the start of cancer treatment.” “Urine output and chemistry results are concerning.” “Please urgently assess for metabolic complications.” Sources: TEAM • TLS · Details and public links in notes
Teaching explanation
The report should include actual verified values and timing in practice. The fictional slide deliberately avoids a diagnostic cutoff or treatment dose. Ask learners what information is still missing and how it will be obtained. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
- Emergency Care BC • Tumor lysis syndrome
- Locator: May 2024; spontaneous or treatment-associated TLS
- https://emergencycarebc.ca/clinical_resource/clinical-summary/tumor-lysis-syndrome/
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
38. Case 5: follow the response to treatment
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 38 / 55 RN Clarity Case 5: follow the response to treatment 01 Track the prescribed laboratory and cardiac monitoring. 02 Assess fluid status, urine output and symptoms. 03 Escalate worsening findings despite the current plan. Sources: LYSIS • TEAM · Details and public links in notes
Teaching explanation
More fluid is not automatically better for every patient. The team adjusts therapy to kidney function, cardiac status and the evolving results. The nurse contributes accurate trends and clinical assessment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
39. Worked comparison: different threats
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 39 / 55 RN Clarity Worked comparison: different threats Fictional recognition exercise • no single value settles the case Context New finding Concern to escalate Heparin exposure Falling platelets + leg symptoms Thrombosis / possible HIT Sickle cell disease New respiratory symptoms Acute chest complication Recent cancer treatment Fever or infection symptoms Urgent infection assessment Which clue changes your next assessment or escalation? Sources: HIT • SCD • NEUT · Details and public links in notes
Teaching explanation
The table tests recognition rather than independent diagnosis. Ask the learner to name the concern, the uncertainty and the immediate assessment. Avoid scoring an unprovided treatment regimen. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
40. The strongest report includes the change
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 40 / 55 RN Clarity The strongest report includes the change State the treatment context. Describe the new findings and timing. Request the response and confirm the next step. Sources: TEAM · Details and public links in notes
Teaching explanation
Ask students to remove vague language such as “labs are bad.” A useful report names the actual result, trend and patient condition when available. Preserve uncertainty without losing urgency. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
41. Practice question: which statement is safest?
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 41 / 55 RN Clarity Practice question: which statement is safest? CHOOSE • EXPLAIN YOUR REASONING 01 A: A low platelet count rules out thrombosis. 02 B: A familiar sickle cell pain admission needs no new assessment. 03 C: New findings must be assessed in the treatment context. Sources: HIT • SCD · Details and public links in notes
Teaching explanation
Original single-best-answer question, not an official NCLEX-RN® item. C is best. A misunderstands HIT risk and B anchors on a previous problem. Ask students to apply C to one of the fictional cases. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
42. Answer: C connects the evidence
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 42 / 55 RN Clarity Answer: C connects the evidence 01 Low platelets can coexist with dangerous clotting. 02 New chest symptoms change a sickle cell assessment. 03 The plan must respond to the current patient. Sources: HIT • SCD • TEAM · Details and public links in notes
Teaching explanation
The rationale should include a concrete next action, not just repeat “assess.” Ask the learner to give a short escalation statement and one reassessment priority. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
43. Recognize cord-compression concerns
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 43 / 55 RN Clarity Recognize cord-compression concerns 01 New back pain with weakness or sensory change is concerning. 02 Bowel or bladder change can add to cord-compression concern. 03 Seek urgent clinical assessment and follow movement instructions. Sources: CORD · Details and public links in notes
Teaching explanation
Spinal cord compression can threaten lasting neurologic function. Do not wait for complete paralysis. The team directs imaging, stabilization and treatment; do not mobilize a patient with suspected instability without appropriate assessment. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Cancer Society • Spinal cord compression
- Locator: Urgent recognition and treatment
- https://cancer.ca/en/treatments/side-effects/spinal-cord-compression
44. Translate common hematology floor terms
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 44 / 55 RN Clarity Translate common hematology floor terms 01 “Counts” = specify which blood-cell result and trend. 02 “Nadir” = the lowest point in a treatment-related count pattern. 03 “Transfusion reaction” = a suspected event needing evaluation.
Teaching explanation
The word nadir should not be used as an exact calendar prediction without the patient’s regimen information. Plain language improves handoff accuracy for learners moving between USA and Canadian settings. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
45. Make a specialty handoff actionable
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 45 / 55 RN Clarity Make a specialty handoff actionable 01 Name the disease and current treatment accurately. 02 State new symptoms, relevant trends and actions taken. 03 Assign responsibility for pending tests and reassessment. Sources: TEAM · Details and public links in notes
Teaching explanation
Include transfusion reactions or suspected medication complications in transitions. The next nurse needs the current plan and unresolved concern, not only the admission diagnosis. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
46. Home teaching should include a response plan
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 46 / 55 RN Clarity Home teaching should include a response plan 01 Explain treatment-specific warning signs and contacts. 02 Check access to medicines, monitoring and follow-up. 03 Ask the patient to explain what they will do if unwell. Sources: NEUT • TEAM · Details and public links in notes
Teaching explanation
Use the oncology or hematology team’s actual instructions. Avoid generic advice that conflicts with a treatment-specific plan. A contact number should be accompanied by guidance about urgent emergency care when needed. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
47. Listen before deciding a symptom is expected
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 47 / 55 RN Clarity Listen before deciding a symptom is expected “How is this different from your usual symptoms?” “When did it start in relation to your treatment?” “What advice were you given for this change?” Sources: TEAM · Details and public links in notes
Teaching explanation
These questions help surface new patterns and existing instructions. They should not delay emergency assessment. Explain why the symptom warrants review without dismissing the patient’s experience. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
48. Avoid three hematology shortcuts
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 48 / 55 RN Clarity Avoid three hematology shortcuts 01 A laboratory label is not the whole clinical picture. 02 Improvement in one symptom does not exclude a complication. 03 Treatment effects need assessment, not automatic reassurance. Sources: ANEMIA • SCD • IMM · Details and public links in notes
Teaching explanation
Ask the learner to identify one example from the cases. The correction is a fuller assessment and appropriate escalation, not a claim that every symptom is a medical emergency. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- NCI • Organ-related inflammation
- Locator: Immunotherapy-associated organ symptoms
- https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation
49. Localize high-risk treatment processes
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 49 / 55 RN Clarity Localize high-risk treatment processes 01 Use current transfusion and oncology emergency pathways. 02 Confirm medication, monitoring and competency requirements. 03 Learn how to reach specialist support in your setting. Sources: TX • TEAM · Details and public links in notes
Teaching explanation
USA and Canadian policies and available therapies differ. Antineoplastic administration, transfusion checks and emergency treatment require the relevant local training and authorization. No universal independent nursing treatment authority is implied. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
50. Teacher debrief: identify the overlooked clue
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 50 / 55 RN Clarity Teacher debrief: identify the overlooked clue Which new finding changed the priority? What prior label could have caused anchoring? What response will you reassess after escalation?
Teaching explanation
Use paired roles: one learner gives the incomplete handoff and another repairs it. Assess the explanation of mechanism, urgency and uncertainty. Speaker notes support teaching beyond the brief slide text. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
51. Evidence guide: blood and transfusion
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 51 / 55 RN Clarity Evidence guide: blood and transfusion NHLBI • Anemia NHLBI • Disseminated intravascular coagulation NHLBI • Thrombotic thrombocytopenic purpura ASH • Heparin-induced thrombocytopenia Canadian Blood Services • Transfusion reactions Sources: ANEMIA • DIC • TTP • HIT • TX · Details and public links in notes
Teaching explanation
Public source links and locators are provided in notes. The deck does not reproduce proprietary scales, component selection tables or treatment doses. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- NHLBI • Anemia
- Locator: Oxygen-carrying function, symptoms and causes
- https://www.nhlbi.nih.gov/health/anemia
- NHLBI • Disseminated intravascular coagulation
- Locator: 2022; clotting, bleeding and underlying-cause treatment
- https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
- NHLBI • Thrombotic thrombocytopenic purpura
- Locator: 2025; small-vessel clotting and specialist treatment
- https://www.nhlbi.nih.gov/health/thrombotic-thrombocytopenic-purpura
- ASH • Heparin-induced thrombocytopenia
- Locator: Guideline overview; prothrombotic adverse drug reaction
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/venous-thromboembolism-guidelines/heparin-induced-thrombocytopenia
- Canadian Blood Services • Transfusion reactions
- Locator: 2022; chapter 10, recognition and initial response
- https://professionaleducation.blood.ca/en/transfusion/clinical-guide/transfusion-reactions
52. Evidence guide: sickle cell and cancer
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 52 / 55 RN Clarity Evidence guide: sickle cell and cancer CDC • Sickle cell acute chest syndrome ASH • Sickle cell disease guidelines NCI • Infection and neutropenia Emergency Care BC • Tumor lysis syndrome Canadian Cancer Society • Tumour lysis syndrome Sources: SCD • ASH • NEUT • TLS • LYSIS · Details and public links in notes
Teaching explanation
These sources support recognition and scope-qualified care. Exact treatment is individualized. The terminology difference between tumor and tumour does not indicate a different syndrome. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- CDC • Sickle cell acute chest syndrome
- Locator: Emergency recognition and respiratory complications
- https://www.cdc.gov/sickle-cell/complications/acute-chest-syndrome.html
- ASH • Sickle cell disease guidelines
- Locator: Pain, transfusion support and complications
- https://www.hematology.org/education/clinicians/guidelines-and-quality-care/clinical-practice-guidelines/sickle-cell-disease-guidelines
- NCI • Infection and neutropenia
- Locator: Urgent infection assessment during cancer treatment
- https://www.cancer.gov/about-cancer/treatment/side-effects/infection
- Emergency Care BC • Tumor lysis syndrome
- Locator: May 2024; spontaneous or treatment-associated TLS
- https://emergencycarebc.ca/clinical_resource/clinical-summary/tumor-lysis-syndrome/
- Canadian Cancer Society • Tumour lysis syndrome
- Locator: Electrolyte pattern, kidney injury and surveillance
- https://cancer.ca/en/treatments/side-effects/tumour-lysis-syndrome
53. Evidence: complications and communication
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 53 / 55 RN Clarity Evidence: complications and communication Canadian Cancer Society • Spinal cord compression NCI • Organ-related inflammation AHRQ • TeamSTEPPS tools Original fictional cases and practice question. Apply current local protocols and patient-specific orders. Sources: CORD • IMM • TEAM · Details and public links in notes
Teaching explanation
Immunotherapy can affect several organs. New diarrhea, cough or other concerning symptoms require assessment in context, not automatic attribution to a benign treatment effect. This is independent educational preparation. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- Canadian Cancer Society • Spinal cord compression
- Locator: Urgent recognition and treatment
- https://cancer.ca/en/treatments/side-effects/spinal-cord-compression
- NCI • Organ-related inflammation
- Locator: Immunotherapy-associated organ symptoms
- https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
54. Follow the pattern beyond the blood count
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 54 / 55 RN Clarity Follow the pattern beyond the blood count Know the treatment context. Notice and communicate the new clinical change. Confirm the response and reassess the patient.
Teaching explanation
End with one concise report from the cases and one plain-language patient explanation. The learner should identify the next reassessment and any unresolved uncertainty. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
55. Notice the change. Connect the clues.
Slide text
RN Clarity C10 / CLINICAL SYSTEMS RN Clarity • Learning for practice 55 / 55 RN Clarity Notice the change. Connect the clues. Treat concerns seriously. Explain clearly. Follow through. RN Clarity • rnclarity.com Independent preparation for the NCLEX-RN® examination. NCLEX-RN® is an NCSBN trademark. RN Clarity is independent and not endorsed by NCSBN.
Teaching explanation
NCLEX® and NCLEX-RN® are registered trademarks of NCSBN. RN Clarity is independent and is not affiliated with, sponsored by or endorsed by NCSBN. Educational preparation, not a clinical order set. Source and scope Sources accessed for this revision: 2026-09-08. Cases and practice dialogue are fictional. Apply patient-specific orders, local protocols and scope requirements.
Sources
- AHRQ • TeamSTEPPS tools
- Locator: SBAR, check-back, handoff and teach-back
- https://www.ahrq.gov/teamstepps-program/resources/modules/index.html
Supports learning and orientation. Follow current local policies and scope of practice.